FDA Approves Unknown Drug — DR REDDYS
# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA214733, expanding its generic pharmaceutical portfolio and positioni…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA214733, expanding its generic pharmaceutical portfolio and positioni…
Zydus Lifesciences announced that FDA has granted approval for its generic drug submission referenced by ANDA217758, potentially impacting the market share of the branded equivalen…
DR REDDYS announced the FDA's approval of its ANDA215820 on May 15, 2026, which is expected to broaden its commercial footprint once the product launches. This regulatory milestone…
Stephen I. Miran has submitted his resignation as a member of the Federal Reserve Board. His resignation will become effective when or shortly before his successor is sworn in.
The Federal Reserve Board published findings from two surveys of senior bank financial officers regarding their preferences on discount window operating days and strategies for man…
# FDA Approves Amneal Pharmaceuticals' Generic Tretinoin Topical Formulation Amneal Pharmaceuticals NY LLC received FDA approval for its generic tretinoin topical formulation (AND…
# FDA Approves Renova Pharmaceuticals' Generic L-Glutamine Oral Formulation Renova Pharmaceuticals LLC has received FDA approval for its generic L-glutamine oral formulation (ANDA…
# FDA Approves Chiesi's New Drug Application NDA219622 Chiesi Pharmaceuticals has received FDA approval for a new drug candidate under application NDA219622, marking an addition t…
Ionetix Corporation announced the FDA approval of Gallium Ga-68 Gozetotide, a generic version of the prostate cancer imaging agent PSMA-11, which is expected to intensify price com…
The Federal Reserve Board published its annual assessment of American household economic conditions for 2025. The report provides data on household finances, employment, and econom…
On May 13, 2026, BEONE MEDICINES USA may experience a significant market impact with the likely approval of a new drug, though the specific substance and indication remain undisclo…
Caplin Steriles Limited has received FDA approval for its ANDA220068 application, granting it authorization to market foscarnet sodium injection in the United States. This approval…
The Federal Reserve Board has terminated enforcement actions with F&M Holding Company, Inc. and Thread Bancorp, Inc. The action indicates these institutions have resolved complianc…
The FDA has finalized its post-market assessment program for food chemicals and initiated a reassessment of BHT and ADA safety. This action is part of the FDA's expanded food safet…
The FDA announced it is seeking stakeholder input on drug repurposing efforts to address unmet medical needs across various diseases and conditions. The initiative aims to leverage…
# FDA Approves Estradiol Transdermal Patch from Encube Ethicals Encube Ethicals, Inc. received FDA approval for its generic estradiol transdermal patch (ANDA218214), expanding the…
The Federal Reserve Board has approved related applications submitted by Columbia Bank MHC and Columbia Financial, Inc. The approval allows these entities to proceed with their reg…
The FDA granted approval for Bizengri (zenocutuzumab-zbco), marking the seventh approval under the National Priority Voucher Pilot Program. The drug treats NRG1 fusion-positive cho…
The FDA released final guidance recommending methodologies for studying drug and biologic safety during pregnancy in the postapproval setting. The guidance aims to improve collecti…
# FDA Approves Micro Labs Generic Drug Application Micro Labs has received FDA approval for its abbreviated new drug application (ANDA 218558), expanding the company's generic pha…